Upcoming FDA decision · February 24, 2027
RARE PDUFA date: FDA decision expected February 24, 2027
194 days to goUltragenyx Pharmaceutical Inc. (RARE) →
The FDA is expected to decide on this application from Ultragenyx Pharmaceutical Inc. by the PDUFA target action date of February 24, 2027. NDA filing. Extracted from SEC filing: 8-K
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
February 24
Target action date
NDA
Stage
Detected
Date confidence
—
FDA designations